Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Adoptive Transfer of Autologous CD25-Depleted, CD3/CD28-Costimulated T Cells After Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma: Long-Term Follow up

Stephen J. Schuster, MD, Nicole A. Aqui, MD, Benjamin Musher, MD, Bruce L. Levine, PhD, Charalambos Andreadis, MD, MS, Elise A. Chong, BA, Sunita D. Nasta, MD, Amanda Gordon, CRNP, Julio Cotte, Zhaohui Zheng, MA, Andrea L. Brennan, Elizabeth Veloso, JD, BSN, Carl H. June, MD

Blood (2012) 120 (21): 1631.

https://doi.org/10.1182/blood.V120.21.1631.1631

Published: 2012

Journal Articles

Maximum Standard Uptake Value (SUVmax) on FDG-PET Imaging Predicts Time to First Treatment in Patients with Low Grade Follicular Lymphoma,

Jakub Svoboda, MD, Elise A. Chong, BA, Emeline R Chong, Sunita D. Nasta, MD, Drew Torigian, MD, Abass Alavi, MD, Stephen J. Schuster, MD

Blood (2011) 118 (21): 4204.

https://doi.org/10.1182/blood.V118.21.4204.4204

Published: 2011

Journal Articles

Phase II Trial of Lenalidomide - Rituximab +/− Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Tahamtan Ahmadi, MD, PhD, Elise A. Chong, BA, Amanda Gordon, CRNP, Nicole A. Aqui, MD, YinYan Xu, Jakub Svoboda, MD, Sunita D. Nasta, MD, Stephen J. Schuster, MD

Blood (2011) 118 (21): 266.

https://doi.org/10.1182/blood.V118.21.266.266

Published: 2011

Journal Articles

Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 2855.

https://doi.org/10.1182/blood.V118.21.2855.2855

Published: 2011

Journal Articles

Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Treated with R-Hypercvad or ASCT

Anthony R Mato, MD, Tania Zielonka, Tatyana Feldman, MD, Jakub Svoboda, MD, Harry Agress, MD, David Panush, MD, Mitchell Miller, MD, Patrick Toth, MD, Elise A Chong, BA, Emeline R Chong, Drew Torigian, MD, Paul M Lizott, Jr., RT, Stephen J. Schuster, MD, Scott D Rowley, MD, Michele L Donato, MD, Stuart L Goldberg, MD, Andrew L Pecora, MD, Andre Goy, MD

Blood (2010) 116 (21): 3131.

https://doi.org/10.1182/blood.V116.21.3131.3131

Published: 2010

Journal Articles

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.

Tahamtan Ahmadi, MD, PhD, Elise A. Chong, BA, Amanda Gordon, BA, BSN, RN, Nicole A. Aqui, MD, Lisa H. Downs, CRNP, Leah Leinbach, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Stephen Janofsky, Tapan N. Maniar, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD

Blood (2009) 114 (22): 1700.

https://doi.org/10.1182/blood.V114.22.1700.1700

Published: 2009

Journal Articles

Comparison of Contrast-Enhanced CT, PET/CT, PET, and Low-Dose Non-Contrast Enhanced CT Imaging of Diffuse Large B-Cell, Follicular, Small Lymphocytic/CLL, and Marginal Zone Lymphomas.

Elise A. Chong, BA, Drew A. Torigian, MD, MA, Abass Alavi, MD, Jakub Svoboda, MD, Anthony R Mato, MD, Sunita Dwvedy Nasta, MD, Lisa H. Downs, CRNP, Stephen J. Schuster, MD

Blood (2009) 114 (22): 1402.

https://doi.org/10.1182/blood.V114.22.1402.1402

Published: 2009

Journal Articles

The Impact of Rituximab Resistance on Overall Survival Rate in Low-Grade Follicular Lymphoma

Shahrzad Abdollahi, Elise A Chong, BA, Rebecca L. Olin, MD, Sunita D. Nasta, MD, Charalambos Andreadis, MD, MSCE, Edward A Stadtmauer, MD, Christopher C Lake, Lisa H Downs, Stephen J. Schuster, MD

Blood (2008) 112 (11): 3783.

https://doi.org/10.1182/blood.V112.11.3783.3783

Published: 2008

NARROW

Adoptive Transfer of Autologous CD25-Depleted, CD3/CD28-Costimulated T Cells After Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma: Long-Term Follow up

Maximum Standard Uptake Value (SUVmax) on FDG-PET Imaging Predicts Time to First Treatment in Patients with Low Grade Follicular Lymphoma,

Phase II Trial of Lenalidomide - Rituximab +/− Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia

Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Treated with R-Hypercvad or ASCT

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.

Comparison of Contrast-Enhanced CT, PET/CT, PET, and Low-Dose Non-Contrast Enhanced CT Imaging of Diffuse Large B-Cell, Follicular, Small Lymphocytic/CLL, and Marginal Zone Lymphomas.

The Impact of Rituximab Resistance on Overall Survival Rate in Low-Grade Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only